semaglutide and breast cancer GLP-1 medications may offer benefits beyond weight loss diabetes management, including improved outcomes for patients who are obese or have type 2 diabetes, according to new research. The study GLP-1 reduces breast cancer mortality

What should clinicians and patients monitor

Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies

This editorial focuses on the compound itself and the model around it

Not that its been formally announced, but its been backordered. So she and her colleagues are switching patients to a daily injectable also from Novo Nordisk

About three or four years ago, Ziyad Al-Aly started to notice something curious in his practice as a nephrologist at the VA Saint Louis Health Care System in Missouri

This was not the case for other intestinal hormones such as GIP